Working Capital Infusion definition

Working Capital Infusion means the portion of the proceeds from the Bridge Loan, if any, used by Capital Partners for working capital. The Working Capital Infusion shall be equal to the total amount of the Bridge Loan, including all accrued and unpaid interest thereon, less the amount of the Payment to Capital Partners.
View Source
Working Capital Infusion is defined in Section 2.1.
View Source

Examples of Working Capital Infusion in a sentence

  • The Investors understand that a Schedule 13E-3 filing with the SEC under Rule 13E-3 (the “Schedule 13e-3 Filing”) will be required in order to consummate the exchange of the Working Capital Infusion for 2,400,000 shares of Company Common Stock and consummate the Merger.

  • The Owl Creek Investors consent to the execution and delivery of the Monroe/Fortress Facility Amendment and the LJH/CIT Intercreditor in the forms attached hereto as Exhibits A and B and agree to fund One Million, One Hundred Sixty-eight Thousand, Eight Hundred and no/100s Dollars ($1,168,800.00) (19.48%) of the Working Capital Infusion, subject to the terms and conditions stated therein and the Participation Agreement.

  • LJH and the Owl Creek Investors understand that a filing with the SEC under Rule 13e-3 will be required in order to consummate the Merger and the exchange of the Working Capital Infusion for 2,400,000 shares of Company Common Stock as provided in the Merger Agreement.

  • The Owl Creek Investors consent to the execution and delivery of the Monroe/Fortress Facility Amendment in substantially the form that has been delivered by LJH to the Owl Creek Investors, pursuant to the Participation Agreement, agree to fund One Million, One Hundred Sixty-eight Thousand, Eight Hundred and no/100s Dollars ($1,168,800.00) (19.48%) of the Working Capital Infusion, subject to the terms and conditions stated therein.

  • LJH has purchased the Monroe Facility and proposes to modify its terms to, among other things, resolve the Defaults thereunder and make available to the Company $6 million of additional funding (the "Working Capital Infusion"), and by working with the Company to obtain amendments to the CIT Facility which will resolve the Defaults thereunder and make available to the Company additional credit to fund its business.

  • The Investors understand that a Schedule 13E-3 filing with the SEC under Rule 13E-3 (the "Schedule 13e-3 Filing") will be required in order to consummate the exchange of the Working Capital Infusion for 2,400,000 shares of Company Common Stock and consummate the Merger.

  • Such payment by the Owl Creek Investors will be made by wire of immediately available funds to the account designated by LJH to the Owl Creek Investors in a written notice provided to the Owl Creek Investors not less than twenty-four (24) hours prior to the funding of the Working Capital Infusion contemplated by the Monroe/Fortress Facility Amendment.